APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains

Keyphrases

• Age-matched 100%
• Alzheimer's Disease 100%
• Non-demented 100%
• Molecular Abnormalities 100%
• APOE Genotype 100%
• Genetic Parameters 100%
• Cerebrovasculature 100%
• APOE4 60%
• Endothelial Cells 40%
• Specificity Protein 1 40%
• Mammalian Target of Rapamycin (mTOR) 40%
• Healthy Controls 40%
• Cerebrovascular Disease 40%
• Astrocytes 40%
• Protein Markers 40%
• APOE ε4 Allele 40%
• Altered Pathway 40%
• EIF2 Signaling 40%
• APOE4 Genotype 40%
• Proteomic Changes 40%
• Genotype 20%
• Risk Factors 20%
• Alzheimer's Disease Pathology 20%
• Type-specific 20%
• Direct Influence 20%
• Smooth muscle Cells 20%
• Disease Control 20%
• MS-MS 20%
• Proteomic Analysis 20%
• Vascular Amyloid 20%
• Specific Marker 20%
• Mitochondrial Dysfunction 20%
• Impaired Autophagy 20%
• Ultra-high Performance Liquid Chromatography (UHPLC) 20%
• Oxidative Phosphorylation (OXPHOS) 20%
• Endoplasmic Reticulum Stress (ER stress) 20%
• APOE2 20%
• Signaling Regulation 20%
• Mitochondrial Bioenergetics 20%
• ApoE3 20%
• K-plex 20%
• EIF2 20%
• Significant Pathways 20%
• Amyloid Clearance 20%
• Disease-modifying Strategies 20%
• Unbiased Proteomics 20%
• Significant Protein 20%
• Cerebrovascular Cells 20%
• Q-Exactive 20%
• Isobaric Mass Tags 20%

Biochemistry, Genetics and Molecular Biology

• Genotyping 100%
• Proteomics 60%
• Allele 40%
• Astrocyte 40%
• mTOR Signaling 40%
• Bioenergy 20%
• Autophagy 20%
• High-Performance Liquid Chromatography 20%
• Oxidative Phosphorylation 20%
• Tandem Mass Spectrometry 20%
• Endoplasmic Reticulum Stress 20%
• Mitochondrial Disorder 20%
• Amyloid Protein 20%
• Apolipoprotein 20%

Neuroscience

• Alzheimer's Disease 100%
• Proteomics 50%
• Astrocyte 33%
• mTOR Signaling 33%
• Apolipoprotein E4 16%
• Autophagy 16%
• Amyloid Protein 16%
• Endoplasmic Reticulum Stress 16%
• Oxidative Phosphorylation 16%
• Risk Factor 16%